1-Aminobenzotriazole

Modify Date: 2024-01-03 12:20:14

1-Aminobenzotriazole Structure
1-Aminobenzotriazole structure
 Common Name 1-Aminobenzotriazole
CAS Number 1614-12-6 Molecular Weight 134.139
Density 1.5±0.1 g/cm3 Boiling Point 319.3±25.0 °C at 760 mmHg
Molecular Formula C6H6N4 Melting Point 81-84 °C(lit.)
MSDS Chinese USA Flash Point 146.9±23.2 °C
Symbol GHS07
GHS07		 Signal Word Warning

 Use of 1-Aminobenzotriazole


1-Aminobenzotriazole is a nonspecific and irreversible inhibitor of cytochrome P450 (P450).

 Names

Name 1-Aminobenzotriazole
Synonym More Synonyms

 1-Aminobenzotriazole Biological Activity

Description 1-Aminobenzotriazole is a nonspecific and irreversible inhibitor of cytochrome P450 (P450).
Related Catalog
Target

P450[1]

In Vitro 1-Aminobenzotriazole (ABT) alone significantly increases the expression levels of CYP2B6 in two different hepatocytes (7.3- and 10.8-fold, respectively). Upon co-treatment with 1-Aminobenzotriazole, the induction of CYP2B6 expression by CITCO or rifampin is potentiated: 12.6- and 4.0-fold for CITCO as well as 3.9- and 2.5-fold for rifampin. 1-Aminobenzotriazole has a greater potentiation effect on CITCO than on rifampin. 1-Aminobenzotriazole alone increases the expression levels of CYP3A4 in tow different hepatocytes (by 2.0- and 3.8-fold). Upon co-treatment with 1-Aminobenzotriazole, the effects of CITCO on CYP3A4 expression levels are potentiated by 3.8- and 6.0- fold as compare to cells treated with CITCO alone[1]. 1-Aminobenzotriazole (ABT) (1 mM) shows pronounced (~95%) inhibition of the formation of N-acetylprocainamide compare with the control without 1-Aminobenzotriazole[2].
In Vivo Oral 1-Aminobenzotriazole (ABT) (100 mg/kg, 2 h predose) decreases the clearance of intravenous procainamide (45%) in rats, accompanied by a decreased N-acetylprocainamide-to-procainamide ratio in urine (0.74 versus 0.21) and plasma (area under the curve ratio 0.59 versus 0.11). The urinary recovery of procainamide increases from 18 to 30%, whereas the recovery of N-acetylprocainamide in urine decreases from 13.3 to 6.5% with 1-Aminobenzotriazole[2]. Pretreatment of rats with 100 mg/kg oral 1-Aminobenzotriazole (ABT) administered 2 hours before a semisolid caloric test meal markedly delays gastric emptying. 1-Aminobenzotriazole also increases stomach weights by 2-fold[3].
Cell Assay Freshly isolated human hepatocytes are used in this study. Briefly, hepatocytes are placed in serum-free Williams’ E media containing 0.1 μM dexamethasone, 10 μg/mL gentamicin, 15 mM HEPES, 2 mM L-glutamine, and 1% ITS. Cells are incubated for 10 hr at 37°C in an atmosphere containing 5% CO2. After recovery, the hepatocytes are treated with media containing CITCO (100 nM), rifampin (10 μM) or vehicle (ethanol), with or without 1-Aminobenzotriazole (ABT) (1 mM) for 72 hr[1].
Animal Admin Male Sprague-Dawley rats (0.26 to 0.30 kg, n=3 per treatment) receive an oral dose of 1-Aminobenzotriazole (ABT) (100 mg/kg, 2 mL/kg) 2 h before a single intravenous bolus of procainamide (10 mg/kg, 2 mL/kg). The control group receives only the intravenous bolus of procainamide without 1-Aminobenzotriazole pretreatment. The vehicle for both 1-Aminobenzotriazole and procainamide is 10% dimethylacetamide/90% water (v/v). Rats are fed 4 h after dosing, and serial blood samples are collected at 0.03, 0.17, 0.25, 0.5, 1, 2, 4, and 6 h postdose. Blood samples are centrifuged using tubes containing K3-EDTA as the anticoagulant to obtain plasma. Urine samples are also collected over 24 h postdose. Plasma and urine samples are frozen at -20°C until analysis[2].
References

[1]. Yang K, et al. Induction of CYP2B6 and CYP3A4 expression by 1-aminobenzotriazole (ABT) in human hepatocytes. Drug Metab Lett. 2010 Aug;4(3):129-33.

[2]. Sun Q, et al. 1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase. Drug Metab Dispos. 2011 Sep;39(9):1674-9.

[3]. Stringer RA, et al. 1-Aminobenzotriazole modulates oral drug pharmacokinetics through cytochrome P450 inhibition and delay of gastric emptying in rats. Drug Metab Dispos. 2014 Jul;42(7):1117-24.

 Chemical & Physical Properties

Density 1.5±0.1 g/cm3
Boiling Point 319.3±25.0 °C at 760 mmHg
Melting Point 81-84 °C(lit.)
Molecular Formula C6H6N4
Molecular Weight 134.139
Flash Point 146.9±23.2 °C
Exact Mass 134.059250
PSA 56.73000
LogP 0.75
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.774
Water Solubility slightly soluble

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H315-H319-H335
Precautionary Statements P261-P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi: Irritant;
Risk Phrases R36/37/38
Safety Phrases S26-S36-S37/39
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2933990090

 Customs

HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Articles54

More Articles
Chemical genetics reveals a complex functional ground state of neural stem cells.

Nat. Chem. Biol. 3(5) , 268-273, (2007)

The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc...

Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device.

Xenobiotica 45(1) , 29-44, (2014)

1. The quantitative prediction of the pharmacokinetic parameters of a drug from data obtained using human in vitro systems remains a significant challenge i.e. prediction of metabolic clearance in hum...

Quantitative assessment of intestinal first-pass metabolism of oral drugs using portal-vein cannulated rats.

Pharm. Res. 32(2) , 604-16, (2015)

To evaluate the impact of intestinal first-pass metabolism (Fg) by cytochrome P4503A (CYP3A) and uridine 5'-diphosphate-glucuronosyltransferases (UGT) on in vivo oral absorption of their substrate dru...

 Synonyms

MFCD00132902
1-Benzotriazolamine,ABT
benzotriazol-1-amine
1H-1,2,3-Benzotriazol-1-amine
1-Benzotriazolamine
1H-Benzo[d][1,2,3]triazol-1-amine
1-Aminobenzotriazole
1H-Benzotriazol-1-amine
Top Suppliers:I want be here

Get all suppliers and price by the below link:

1-Aminobenzotriazole suppliers

Price: $55/10mM*1mLinDMSO

Reference only. check more 1-Aminobenzotriazole price

Related Compounds: More...
n-benzyl-1-aminobenzotriazole
105026-59-3
N-a-Methylbenzyl-1-aminobenzotriazole
105026-61-7
N-alpha-ethylbenzyl-1-aminobenzotriazole
132195-09-6
1-(3-Chlorophenyl)-4-propylpiperazine
144146-59-8
[1-[4-(4-aminophenyl)sulfanylphenyl]ethylideneamino]urea
144141-11-7
1,4,7,13-tetramethyl-1,4,7,10,13,16-hexazacyclooctadecane
144140-24-9
acetic acid,[dimethyl(trimethylsilyloxy)silyl]oxy-[[[hydroxy(dimethyl)silyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilane
144139-44-6
1-(2-methoxyphenyl)-4-(2-phenylethyl)piperazine
144146-62-3
1-bromo-2,5-bis(chloromethyl)-4-methyl-benzene
56403-26-0
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
tert-Butyl-DL-alanine
1375289-11-4
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
N-[3-(Aminooxy)propyl]-N-butyl-1-butanamine
127437-46-1
Chemsrc provides 1-Aminobenzotriazole(CAS#:1614-12-6) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of 1-Aminobenzotriazole are included as well.>> amp version: 1-Aminobenzotriazole

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved